Hormonal therapy in the senescence: Prostatic microenvironment structure and adhesion molecules

Micron

Volumn 42, Issue 6, 2011, Pages 642-655

  Montico, Fábio ^a   Hetzl, Amanda Cia ^a   Cândido, Eduardo Marcelo ^a   Fávaro, Wagner José ^a,b   Cagnon, Valéria Helena Alves ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Dystroglycans; Prostate; Senescence; Steroid hormones; Ultrastructure

Indexed keywords

DYSTROGLYCANS; PROSTATE; SENESCENCE; STEROID HORMONES; ULTRASTRUCTURE;

ENDOCRINOLOGY; HORMONES; LIGHT TRANSMISSION; MAINTAINABILITY; MOLECULES; RATS; SURGERY; TISSUE; TRANSMISSION ELECTRON MICROSCOPY; VEGETABLE OILS;

DISEASE CONTROL;

CELL ADHESION MOLECULE; DYSTROGLYCAN; SEX HORMONE;

AGING; ANIMAL; ARTICLE; BLOOD; CASTRATION; DRUG EFFECT; EPITHELIUM CELL; HORMONE SUBSTITUTION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; PROSTATE; PROSTATE DISEASE; RAT; SPRAGUE DAWLEY RAT; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WESTERN BLOTTING;

AGING; ANIMALS; BLOTTING, WESTERN; CASTRATION; CELL ADHESION MOLECULES; DYSTROGLYCANS; EPITHELIAL CELLS; GONADAL STEROID HORMONES; HORMONE REPLACEMENT THERAPY; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; PROSTATE; PROSTATIC DISEASES; RATS; RATS, SPRAGUE-DAWLEY;

ARACHIS; ARACHIS HYPOGAEA; RATTUS;

EID: 79955639888     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micron.2011.03.004     Document Type: Article

References (67)

1. Acosta S., Dizeyi N., Feinstein R., Pierzynowski S., Abrahamsson P.A. Long-term testosterone stimulation induces hyperplasia in the guinea-pig prostate. Prostate Cancer Prostatic Dis. 2004, 7:227-231.
2. Banerjee P.P., Banerjee S., Dorsey R., Zirkin B.R., Brown T.R. Age- and lobe-specific responses of the Brown Norway rat prostate to androgen. Biol. Reprod. 1994, 51:675-684.
3. Banerjee P.P., Banerjee S., Lai J.M., Strandberg J.D., Zirkin B.R., BROWN T.R. Age-dependent and lobe-specific spontaneous hyperplasia in the Brown Norway rat prostate. Biol. Reprod. 1998, 59:1163-1170.
4. Banerjee S., Banerjee P.P., Brown T.R. Castration-induced apoptotic cell death in the Brown Norway rat prostate decreases as a function of age. Endocrinology 2000, 141:821-832.
5. Banerjee P.P., Banerjee S., Brown T.R. Increased androgen receptor expression correlates with development of age-dependent, lobe-specific spontaneous hyperplasia of the Brown Norway rat prostate. Endocrinology 2001, 142:4066-4075.
6. Berry P.A., Maitland N.J., Collins A.T. Androgen receptor signalling in prostate: effects of stromal factors on normal and cancer stem cells. Mol. Cell. Endocrinol. 2008, 288:30-37.
7. Brennan P.A., Jing J., Ethunandan M., Górecki D. Dystroglycan complex in cancer. Eur. J. Surg. Oncol. 2004, 30:589-592.
8. Bianchi-Frias D., Vakar-Lopez F., Coleman I.M., Plymate S.R., Reed M.J., Nelson P.S. The effects of aging on the molecular and cellular composition of the prostate microenvironment. PLoS One 2010, 5. Epub ahead of print.
9. Cordeiro R.S., Scarano W.R., Campos S.G., Santos F.C., Vilamaior P.S., Góes R.M., Taboga S.R. Androgen receptor in the Mongolian gerbil ventral prostate: Evaluation during different phases of postnatal development and following androgen blockage. Micron 2008, 39:1312-1324.
10. Cross S.S., Lippitt J., Mitchell A., Hollingsbury F., Balasubramanian S.P., Reed M.W.R., Eaton C., Catto J.W., Hamdy F., Winder S.J. Expression of β-dystroglycan is reduced or absent in many human carcinomas. Histopathology 2008, 53:561-566.
11. Cunha G.R., Hayward S.W., Wang Y.Z. Role of stroma in carcinogenesis of the prostate. Differentiation 2002, 70:473-485.
12. De Marzo A.M., Marchi V.L., Epstein J.I., Nelson W.G. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am. J. Pathol. 1999, 155:1985-1992.
13. Ellem S.J., Risbridger G.P. The dual, opposing roles of estrogen in the prostate. Ann. N. Y. Acad. Sci. 2009, 1155:174-186.
14. Flórez M.G., Carvalho H.F. Célula Epitelial Prostática. Células: uma abordagem multidisciplinar 2005, 335-345. Manole, Barueri. H.F. Carvalho, C.B. Collares-Buzato (Eds.).
15. Franck-Lissbrant I., Häggström S., Damber J.E., Bergh A. Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology 1998, 139:451-456.
16. Graham R.C., Karnovsky M.J. The histochemical demonstration of monoamine oxidase activity by coupled peroxidatic oxidation. J. Histochem. Cytochem. 1965, 13:604-605.
17. Härkönen P.L., Mäkelä S.I. Role of estrogens in development of prostate cancer. J. Steroid Biochem. Mol. Biol. 2004, 92:297-305.
18. Henry M.D., Cohen M.B., Campbell K.P. Reduced expression of dystroglycan in breast and prostate cancer. Hum. Pathol. 2001, 32:791-795.
19. Hildebrand R.K., Naslund M.J., Oesterling J.E., Coffey D.S. Influence of age, strain, and the testes on rat prostate hormone sensitivity. Prostate 1991, 18:81-89.
20. Hsing A.W. Hormones and prostate cancer: what's next?. Epidemiol. Rev. 2001, 23:42-58.
21. Imamov O., Shim G.J., Warner M., Gustafsson J.A. Estrogen receptor beta in health and disease. Biol. Reprod. 2005, 73(5):866-871.
22. Jorcyk C.L., Liu M.L., Shibata M.A., Maroulakou I.G., Komschlies K.L., McPhaul M.J., Resau J.H., Green J.E. Development and characterization of a mouse prostate adenocarcinoma cell line: ductal formation determined by extracellular matrix. Prostate 1998, 34:10-22.
23. Junqueira L.C., Bignolas G., Brentani R.R. Picrossirius staining plus polarization microscopy, a specific method of collagen detection in tissue sections. Histochem. J. 1979, 11:447-455.
24. Knox J.D., Cress A.E., Clark V., Manriquez L., Affinito K.S., Dalkin B.L., Nagle R.B. Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am. J. Pathol. 1994, 145:167-174.
25. Krieg M., Nass R., Tunn S. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J. Clin. Endocrinol. Metab. 1993, 77:375-381.
26. Krtolica A., Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int. J. Biochem. Cell. Biol. 2002, 34:1401-1414.
27. Lau K.M., Tam N.N., Thompson C., Cheng R.Y., Leung Y.K., Ho S.M. Age-associated changes in histology and gene-expression profile in the rat ventral prostate. Lab. Invest. 2003, 83:743-757.
28. Leav I., Merk F.B., Kwan P.W., Ho S.M. Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. Prostate 1989, 15:23-40.
29. Leav I., Lau K.M., Adams J.Y., McNeal J.E., Taplin M.E., Wang J., Singh H., Ho S.M. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am. J. Pathol. 2001, 159:79-92.
30. Losasso C., Di Tommaso F., Sgambato A., Ardito R., Cittadini A., Giardina B., Petrucci T.C., Brancaccio A. Anomalous dystroglycan in carcinoma cell lines. FEBS Lett. 2000, 484:194-198.
31. Marker P.C., Donjacour A.A., Dahiya R., Cunha G.R. Hormonal, cellular, and molecular control of prostatic development. Dev. Biol. 2003, 253:165-174.
32. Markopoulos A.K., Poulopoulos A.K., Kayavis I., Papanayotou P. Immunohistochemical detection of insulin-like growth factor-I in the labial salivary glands of patients with Sjögren's syndrome. Oral. Dis. 2000, 6:31-34.
33. Marks L.S., Mazer N.A., Mostaghel E., Hess D.L., Dorey F.J., Epstein J.I., Veltri R.W., Makarov D.V., Partin A.W., Bostwick D.G., Macairan M.L., Nelson P.S. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA 2006, 296:2351-2361.
34. Miki J. Investigations of prostate epithelial stem cells and prostate cancer stem cells. Int. J. Urol. 2009, 17:139-147.
35. Montgomery D.C. Design and Analysis of Experiments 1991, John Wiley & Sons, New York. 3rd ed.
36. Morales A. Androgen replacement therapy and prostate safety. Eur. Urol. 2002, 41:113-120.
37. Morrissey C., Buser A., Scolaro J., O'Sullivan J., Moquin A., Tenniswood M. Changes in hormone sensitivity in the ventral prostate of aging Sprague-Dawley rats. J. Androl. 2002, 23:341-351.
38. Niu Y.N., Xia S.J. Stroma-epithelium crosstalk in prostate cancer. Asian J. Androl. 2009, 11:28-35.
39. Oliveira S.M., Vilamaior P.S.L., Corradi L.S., Góes R.M., Taboga S.R. Cellular and extracellular behavior in the gerbil (Meriones unguiculatus) ventral prostate following different types of castration and the consequences of testosterone replacement. Cell Biol. Int. 2007, 31:235-245.
40. Pelletier G. Effects of estradiol on prostate epithelial cells in the castrated rat. J. Histochem. Cytochem. 2002, 50:1517-1524.
41. Prins G.S., Jung M.H., Vellanoweth R.L., Chatterjee B., Roy A.K. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia. Dev. Genet. 1996, 18:99-106.
42. Prins G.S., Birch L., Couse J.F., Choi I., Katzenellenbogen B., Korach K.S. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice. Cancer Res. 2001, 61:6089-6097.
43. Reynolds E.S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell Biol. 1963, 17:208-212.
44. Risbridger G.P., Bianco J.J., Ellem S.J., McPherson S.J. Oestrogens and prostate cancer. Endocr. Relat. Cancer 2003, 10:187-191.
45. Sáttolo S., Carvalho C.A.F., Cagnon V.H.A. Influence of hormonal replacement on the ventral lobe of the prostate of rats (Rattus norvegicus albinus) submitted to chronic ethanol treatment. Tissue Cell. 2004, 36:417-430.
46. Scarano W.R., Vilamaior P.S.L., Taboga S.R. Tissue evidence of the testosterone role on the abnormal growth and aging effects reversion in the gerbil (Meriones unguiculatus) prostate. Anat. Rec. A 2006, 288:1190-1200.
47. Schulman C., Lunenfeld B. The aging male. World J. Urol. 2002, 20:4-10.
48. Sgambato A., Brancaccio A. The dystroglycan complex: from biology to cancer. J. Cell Physiol. 2005, 205:163-169.
49. Sgambato A., De Paola B., Migaldi M., Di Salvatore M., Rettino A., Rossi G., Faraglia B., Boninsegna A., Maiorana A., Cittadini A. Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells. J. Cell Physiol. 2007, 213:528-539.
50. Singh J., Itahana Y., Knight-Krajewski S., Kanagawa M., Campbell K.P., Bissell M.J., Muschler J. Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res. 2004, 64:6152-6159.
51. Slayter M.V., Anzano M.A., Kadomatsu K., Smith J.M., Sporn M.B. Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: a system for histological scoring and grading. Cancer Res. 1994, 54:1440-1445.
52. Sprando R.L. Perfusion of rat testis through the heart using heparin. Histological and Histopathological Evaluation of the Testis 1990, 277-280. Cache River Press, Clearwater. L.D. Russell, A.P.S. Ettilin, E.D. Cleeg (Eds.).
53. Srinivasan G., Campbell E., Bashirelahi N. Androgen, estrogen and progesterone receptors in normal and aging prostates. Microsc. Res. Technol. 1995, 30:293-304.
54. Sugimura Y., Cunha G.R., Donjacour A.A. Morphogenesis of ductal networks in the mouse prostate. Biol. Reprod. 1986, 34:961-971.
55. Suzuki H., Nakada T. Alteration of collagen biosynthesis and analysis of type I and type III collagens of prostate in young rats following sex hormone treatments. Arch. Androl. 1996, 36:205-216.
56. Taipale J., Keski-Oja J. Growth factors in the extracellular matrix. FASEB J. 1997, 11:51-59.
57. Toorians A.W., Kelleher S., Gooren L.J., Jimenez M., Handelsman D.J. Estimating the contribution of the prostate to blood dihydrotestosterone. J. Clin. Endocrinol. Metab. 2003, 88:5207-5211.
58. Tuxhorn J.A., Ayala G.E., Rowley D.R. Reactive stroma in prostate cancer progression. J. Urol. 2001, 166:2472-2483.
59. Van Leenders G.J., Gage W.R., Hicks J.L., Van Balken B., Aalders T.W., Schalken J.A., De Marzo A.M. Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am. J. Pathol. 2003, 162:1529-1537.
60. Van Leenders G.J., Schalken J.A. Epithelial cell differentiation in the human prostate epithelium: implications for the pathogenesis and therapy of prostate cancer. Crit. Rev. Oncol. Hematol. 2003, 46:S3-S10.
61. Vilamaior P.S.L., Felisbino S.L., Taboga S.R., Carvalho H.F. Collagen fiber reorganization in the rat ventral prostate following androgen deprivation: a possible role for smooth muscle cells. Prostate 2000, 45:253-258.
62. Wang W., Bergh A., Damber J.E. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 2009, 69:1378-1386.
63. Watson M.L. Staining of tissues sections for electron microscopy with heavy metals. J. Biophys. Biochem. Cytol. 1958, 4:475-478.
64. Weihua Z., Makela S., Andersson L.C., Salmi S., Saji S., Webster J.I., Jensen E.V., Nilsson S., Warner M., Gustafsson J.A. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc. Natl. Acad. Sci. 2001, 98:6330-6335.
65. Weihua Z., Warmer M., Gustafsson J.A. Estrogen receptor beta in the prostate. Mol. Cell Endocrinol. 2002, 193:1-5.
66. Winder S.J. The complexities of dystroglycan. Trends Biochem. Sci. 2001, 26:118-124.
67. Zar J.H. Biostatistical Analysis 1999, Prentice Hall Upper, New Jersey. 4th ed.